Blog

Using synthetic biology, the IITChicago iGEM team aims to harness the power of a patient's own genetic system to regulate choleste...

The SUPERBUGBUSTER project from the French Lyon based team envisions a future where antibiotics remain effective.

Top tips for culturing iPSC-derived microglia

The entrepreneur reflects on his experiences in the world of biologics, winning a Nobel and his role on the bit.bio board.

Exon skipping therapy with antisense oligonucleotides is a promising therapy for DMD. This blog covers the underlying mechanisms o...

Marija Kesic, Research Assistant at bit.bio transitioned from former iGEM competitor to mentor. She discusses the role she plays i...

ALS and FTD are closely related diseases, both showing protein aggregation and axon degeneration. This blog covers similarities be...

Our CEO reflects on bit.bio's involvement in the recent 10 Downing Street discussion and launch of the engineering biology call fo...